Skip to main content

Articles By Jack Cush, MD

acr_session2.jpeg

EULAR 2025 – Day 3 Report

Highlights from today included presentations on imaging in vasculitis, a debate on whether to treat high risk pre-clinical RA, and EULAR Recommendations on a) Treatment of interstitial lung disease (ILD); b) Physical Activity in people with arthritis; and c) EULAR disease activity score for antiphospholipid syndrome and d) the management of SLE nephritis. Below are a few others that caught my eye today.

Read Article
lupus SLE

Social Determinants of Health in SLE

Social determinants of health (SDH), such as socioeconomic status and educational background are factors that are increasingly recognised as critical contributors to health outcomes in chronic diseases.

Read Article
EULAR,poster

EULAR 2025 – Day 2 Report

Day 2 was a full agenda for those attending EULAR 2025 in Barcelona with sessions on the management of RA, Behcets, Lupus and Hand Osteoarthritis. Clinical overviews on MAS, Ehlers-Danlos, Difficult to treat RA and PsA offered a wide variety of options to rheumatologists. Here are a few interesting presentations from today.

Read Article
Conv3.jpg

EULAR 2025 - Day 1 Report

Wednesday was Day One at EULAR 2025 in Barcelona. Thousands from around the world gathered, eager to reunite at this international educational forum. Below are a few of my favorites from Day 1.

Read Article
knee.injx_.lat_.jpg

Intraarticular IL-1Ra Gene Therapy in Knee Osteoarthritis

De la Vega et al. have published in Science Translational Medicine the efficacy of an IL-1Ra gene therapy in adults with knee osteoarthritis (OA).

Read Article
brain headache neuro

Transcranial Stimulation is Effective in Fibromyalgia

A randomized, controlled clinical trial in fibromyalgia (FM) has shown the efficacy of transcranial direct current stimulation (A-tDCS) (along with exercise and pain neuroscience education [PNE]), in alleviating the pain. 

Read Article
GCA,woman

Secukinumab Use in Refractory Giant Cell Arteritis

In 2023, the phase 2 TitAIN study showed that the effectiveness and safety of secukinumab in 52 patients with giant cell arteritis (GCA) who had an inadequate response to tocilizumab.

Read Article
early.ra_.2.jpg

2025 EULAR/ACR Risk Stratification Criteria for At-Risk Arthralgia

A collaborative EULAR/ACR expert panel has established criteria for arthralgia patients at risk (clinically suspect arthralgia) to progress to chronic rheumatoid arthritis (RA).

Read Article
RheumNow Podcast square

MTX Fails Knee OA (6.6.2025)

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com

Read Article
labs2.jpg

HLA-B27 Testing in Practice

Analysis of testing for human leukocyte antigen B27 (HLA-B27) in a teaching center shows HLA-B27 testing was frequently performed by rheumatologists and nonrheumatologists for a broad spectrum of indications and primarily as a screening test. 

Read Article
×